Observational studyInternational journal of hematology2025

Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study.

Tsuyoshi Muta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.